Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin. [electronic resource]
Producer: 20161213Description: 33-43 p. digitalISSN:- 1573-7217
- Aspirin -- pharmacology
- Breast Neoplasms -- genetics
- Cell Proliferation -- drug effects
- Class I Phosphatidylinositol 3-Kinases
- Cytostatic Agents -- pharmacology
- Female
- Glycogen Synthase Kinase 3 beta -- metabolism
- Humans
- MCF-7 Cells
- Mutation
- Phosphatidylinositol 3-Kinases -- genetics
- Phosphorylation
- Proto-Oncogene Proteins p21(ras) -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.